Metformin Omega-3 Statin Compounded Composition

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current pharmaceutical formulations of metformin, omega-3 fatty acids, and statins are limited in their ability to enhance health effects due to their single dosage form, lacking a compounded composition that combines these active ingredients effectively.

Innovation Solution

A compounded composition comprising metformin, omega-3 fatty acids, and statins, with optional vitamins, formulated in various ratios and forms (e.g., metformin:omega-3 fatty acids:statin = 50-500:1000:1-300 by weight ratio, including EPA and DHA in ethyl, triglyceride, or dry powder forms, and statins as chemically synthesized or red yeast rice, optimized for oral dosage forms like capsules or pills.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If single dosage form is used for metformin, omega-3 fatty acids, and statins, then each ingredient can be administered separately, but the health enhancement effect is limited and requires higher individual dosages

Engineering Contradiction:
Improvehealth enhancement effectVSAvoidindividual ingredient dosage
Core Design Contradiction:
ReliabilityVSQuantity of substance

Solution Approach 1:

The patent combines metformin, omega-3 fatty acids, and statins into a single compounded composition dosage form. This merging of multiple active ingredients into one formulation allows for synergistic effects that enhance health benefits while reducing the required dosage of each individual ingredient compared to separate administrations.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The invention creates a composite pharmaceutical composition containing multiple active ingredients (metformin, omega-3 fatty acids, statins, and optionally vitamins) in specific ratios. This composite formulation leverages the complementary mechanisms of action of each ingredient to achieve greater therapeutic effect with lower dosages of individual components.

Inventive Principle:
Principle #40Composite materials

2Reliability

If multiple single dosage forms are used for metformin, omega-3 fatty acids, and statins, then each ingredient can be administered separately, but the device complexity and administration burden increase

Engineering Contradiction:
Improvehealth enhancement effectVSAvoiddosage form complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent consolidates multiple separate dosage forms into a single compounded composition that contains metformin, omega-3 fatty acids, and statins together. This reduces the number of pills or formulations a patient must take while maintaining or enhancing the therapeutic effect, thereby simplifying the administration process.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The compounded composition serves multiple functions simultaneously by delivering three different active ingredients with distinct mechanisms of action in a single dosage form. This multi-functional approach eliminates the need for multiple separate medications while achieving comprehensive health benefits.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Reliability

If higher dosages of individual ingredients are used, then the health enhancement effect can be achieved, but the side effects and health costs increase

Engineering Contradiction:
Improvehealth enhancement effectVSAvoidside effects
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

By combining metformin, omega-3 fatty acids, and statins in a single compounded composition, the patent achieves synergistic effects that allow lower dosages of each individual ingredient to produce the desired health enhancement effect. This reduces the side effects associated with higher dosages of single ingredients.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The invention optimizes the dosage parameters of each active ingredient within the compounded composition. By carefully selecting the ratios and amounts of metformin, omega-3 fatty acids, and statins, the formulation achieves maximum therapeutic effect while minimizing adverse effects that would occur with higher individual dosages.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS20210121419A1Metformin compounded composition and method thereof
Publication Date: 2021.04.29 ZHOUSHAN SANHE BIOTECH CO LTD
  • US20210121419A1 patent drawing

AI summary

The present disclosure is related to a metformin compounded composition and application thereof. The disclosure provides active ingredients of composition dosage forms, comprising active ingredients including metformin, omega-3 fatty acid, statin, and vitamins. The whole or part of the active ingredients can be manufactured into a single dosage form for preventing or treating a special disease or enhance health in general. The diseases that can be prevented or treated include cardiovascular diseases, nervous system diseases, cancer, diabetes, autoimmune diseases, or any other diseases that can be treated with the provided formulations. Because of the broad applicability for preventing diseases and enhancing health, the application of the invented formulation may provide “health and longevity” for general population.